Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of DS107E DGLA cream in mild to moderate acne vulgaris
2012-004965-41Phase 2Completed
- Sponsor
- DS Biopharma
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of DS107E in acne vulgaris, sponsored by DS Biopharma. Started Dec 2012; status: completed.
02
Drugs
DS107E
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2012-004965-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004965-41.